| Pharmaceutical active ingredients: |
| Ondansetron Hydrochloride |
| Available forms, composition and doses of Ondansetron: |
| Tablets; Oral; Ondansetron Hydrochloride 24 mgTablets; Oral; Ondansetron Hydrochloride 4 mgTablets; Oral; Ondansetron Hydrochloride 8 mg |
| Ondansetron medical category: |
| Human:5-HT3 Receptor AntagonistsAntiemeticsSupportive care therapy |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| A04AA01 - Ondansetron |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Pliva |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Ondansetron | Ondansetron | Okasa Pharma |
| Ondansetron | Ondansetron Hydrochloride Dihydrate | Omega Laboratories |
| Ondansetron | Ondansetron Hydrochloride Dihydrate | Pharma Strides Canada Corporation |
| Ondansetron | Ondansetron Hydrochloride Dihydrate | Pharmaceutical Partners of Canada |
| Ondansetron | Ondansetron Hydrochloride | PharmaForce |
| Ondansetron | Ondansetron Hydrochloride Dihydrate | Pro Doc |
| Ondansetron | Ondansetron; Ondansetron Hydrochloride Dihydrate | Qualimed Pharma |
| Ondansetron | Ondansetron Hydrochloride Dihydrate | Ranbaxy |
| Ondansetron | Ondansetron; Ondansetron Hydrochloride Dihydrate | Ratiopharm |
| Ondansetron | Ondansetron Hydrochloride | Renaudin Laboratoire |